+ Site Statistics
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on LinkedInFollow on LinkedIn

+ Translate

Endorphin induced increase in striatal dopamine turnover

Endorphin induced increase in striatal dopamine turnover

Life Sciences 23(9): 961-970

Human .beta.-endorphin administered intracisternally in a dose of 15 .mu.g/rat increased striatal concentrations of the dopamine metabolites, 3,4-dihydroxyphenylacetic acid (DOPAC) and homovanillic acid (HVA) as well as producing catalepsy. These effects were inhibited by naloxone. Pargyline-induced decreases in striatal DOPAC and HVA were greater in endorphin-treated than in saline-treated animals, supporting the concept that .beta.-endorphin increases striatal dopamine turnover. .beta.-endorphin increased the rate of decline in striatal dopamine concentration following synthesis inhibition with .alpha.-methyltyrosine, further suggesting that endorphin increases striatal dopamine turnover. .beta.-endorphin and probenecid interacted competitively to decrease the effects of each other to increase striatal HVA. Naloxone prevented the effect of endorphin to decrease the HVA response to probenecid. Probenecid cannot be used to assess the effects of endorphin on striatal dopamine turnover. If .beta.-endorphin acts presynaptically to decrease dopamine release in striatum, the increases in striatal DOPAC and HVA probably represent a compensatory attempt to increase dopamine synthesis. Although turnover of dopamine to its metabolites is increased, dopamine release may be suppressed by .beta.-endorphin.

(PDF emailed within 1 workday: $29.90)

Accession: 005359019

Download citation: RISBibTeXText

Related references

β-endorphin-induced increase in striatal dopamine turnover. Life Sciences 23(9): 961-970, 1978

beta-Endorphin-induced increase in striatal dopamine turnover. Life Sciences 23(9): 961-970, 1978

Effects of intra ventricular injections of beta endorphin on dopamine levels and turnover in the unanesthetized male rat evidence for an increase of dopamine turnover in the caudatus and in the limbic fore brain and for a decrease of dopamine turnover in the median eminence. Acta Pharmacologica et Toxicologica Supplementum 41(4): 48, 1977

Effects of striatal lesions with kainic acid on morphine-induced "catatonia" and increase of striatal dopamine turnover. Naunyn-Schmiedeberg's Archives of Pharmacology 317(1): 44-50, 1981

Effects of aminooxy acetic acid and baclofen on the catalepsy and on the increase of meso limbic and striatal dopamine turnover induced by haloperidol in rats. Acta Pharmacologica et Toxicologica 39(3): 393-400, 1976

Systemic proteasomal inhibitor exposure enhances dopamine turnover and decreases dopamine levels but does not affect MPTP-induced striatal dopamine depletion in mice. Synapse 62(2): 85-90, 2007

Nonopiate beta endorphin fragments and dopamine 2. beta endorphin 2 9 enhances apo morphine induced stereotypy following sub cutaneous and intra striatal injection. Neuropharmacology 21(11): 1103-1110, 1982

Non-opiate beta-endorphin fragments and dopamine--II. beta-Endorphin 2-9 enhances apomorphine-induced stereotypy following subcutaneous and intra-striatal injection. Neuropharmacology 21(11): 1103-1109, 1982

Novel sites of action for deprenyl in MPTP-parkinsonism: metabolite-mediated protection against striatal neurotoxicity and suppression of MPTP-induced increase of dopamine turnover in C57BL mice. Progress in Brain Research 106: 155-171, 1995

Increase of striatal dopamine turnover by stress in MPTP-treated mice. Clinical Neuropharmacology 11(4): 360-368, 1988

Increase of striatal dopamine turnover by drugs interference with granular storage or receptor blockade. European Journal of Pharmacology 42(2): 155-160, 1977

Neurotoxin 1 methyl 4 phenyl 1 2 3 6 tetrahydropyridine decreases striatal dopamine and tetrahydrobiopterin levels and increases striatal dopamine turnover in mice. Journal of Neurochemistry 44(SUPPL): S189, 1985

Increased duration of dopamine receptor antagonist induced effects on both behavior and striatal dopamine turnover by repeated testing in rats. Pharmacology & Toxicology 63(2): 114-117, 1988

Effects of intra striatal administration of high potassium and calcium solution on gamma butyro lactone induced increase in striatal dopamine content of the rat. Japanese Journal Of Pharmacologyppl: 73p, 1982

Correlation between drug-induced supersensitivity of dopamine dependent striatal mechanisms and the increase in striatal content of the Ca2+regulated protein activator of cAMP phosphodiesterase. Naunyn-Schmiedeberg's Archives of Pharmacology 301(2): 121-127, 1977